================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
----------------
SCHEDULE TO
(RULE 13e-4)
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR SECTION 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
----------------
CELESTICA INC.
(NAME OF SUBJECT COMPANY (ISSUER) AND FILING PERSON)
Liquid Yield Option(TM) Notes due 2020 (Zero Coupon -- Subordinated)
(TITLE OF CLASS OF SECURITIES)
15101QAA6
(CUSIP NUMBER OF CLASS OF SECURITIES)
Kaye Scholer LLP
425 Park Avenue
New York, New York
Attention: Managing Attorney's Office
(212) 836-8000
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO RECEIVE
NOTICES AND COMMUNICATIONS ON BEHALF OF THE FILING PERSON)
----------------
COPIES TO:
Lynn Toby Fisher, Esq. I. Berl Nadler, Esq.
Joel I. Greenberg, Esq. Davies Ward Phillips & Vineberg LLP
Kaye Scholer LLP 1 First Canadian Place, Suite 4400
425 Park Avenue Toronto, Ontario
New York, New York 10022 Canada M5X 1B1
(212) 836-8000 (416) 863-0900
----------------
CALCULATION OF FILING FEE
TRANSACTION VALUATION* AMOUNT OF FILING FEE
U.S.$352,000,000 U.S.$41,431
* Calculated solely for purposes of determining the filing fee. The purchase
price of the Liquid Yield Option(TM) Notes due 2020 (Zero Coupon-
Subordinated), as described herein, is $572.82 per $1,000 principal
amount at maturity. As of June 30, 2005, there was approximately $614.4
million in aggregate principal amount at maturity outstanding, resulting
in an aggregate maximum purchase price of approximately $352.0 million.
The amount of the filing fee is calculated by multiplying the transaction
value by 0.00011770.
/ / Check the box if any part of the fee is offset as provided by Rule
0-11(a)(2) and identify the filing with which the offsetting fee was
previously paid. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
Amount Previously Paid: Not applicable. Filing Party: Not applicable.
Form or Registration No.: Not applicable. Date Filed: Not applicable.
/ / Check the box if the filing relates solely to preliminary communications
made before the commencement of a tender offer.
/ / Check the appropriate boxes below to designate any transactions to which
the statement relates:
/ / third-party tender offer subject to Rule 14d-1.
/X/ issuer tender offer subject to Rule 13e-4.
/ / going private transaction subject to Rule 13e-3.
/ / amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the
results of the tender offer: / /
================================================================================
INTRODUCTORY STATEMENT
This Tender Offer Statement on Schedule TO-I ("Schedule TO-I") is filed by
Celestica Inc., an Ontario, Canada corporation ("Celestica"), and relates to the
offer by Celestica to purchase the Liquid Yield Option(TM) Notes due 2020 (Zero
Coupon-Subordinated) issued by Celestica on August 1, 2000 (the "Securities"),
upon the terms and subject to the conditions set forth in the Indenture (as
defined below), Celestica's notice, dated July 5, 2005 (the "Company Notice"),
the Securities and the related offer materials filed as Exhibits (a)(1)(A) to
(d) to this Schedule TO-I (which Company Notice and related offer materials,
as amended or supplemented from time to time, collectively constitute the
"Option"). The Securities were issued pursuant to an Indenture, dated as of
August 1, 2000, between Celestica and JPMorgan Chase Bank, N.A. (as successor to
The Chase Manhattan Bank), as Trustee ("Trustee") (the "Indenture").
The Option will expire at 5:00 p.m., Eastern Daylight Time, on August 2,
2005. This Schedule TO-I is intended to satisfy the disclosure requirements
of Rule 13e-4(c)(2) under the Securities Exchange Act of 1934, as amended
(the "Exchange Act").
ITEMS 1 THROUGH 9.
Celestica is the issuer of the Securities and is offering to purchase all
of the Securities if tendered by the holders under the terms and subject to the
conditions set forth in the Indenture, Company Notice, the Securities and the
related offer materials filed as Exhibits (a)(1)(A) to (d). The Securities
are convertible into subordinate voting shares of Celestica. Celestica maintains
its registered and principal executive offices at 1150 Eglinton Avenue East,
Toronto, Ontario, Canada M3C 1H7 and its telephone number is (416) 448-5800. As
permitted by General Instruction F to Schedule TO, all of the information set
forth in the Option is incorporated by reference into this Schedule TO-I.
ITEM 10. FINANCIAL STATEMENTS.
(a) Celestica believes that its financial condition is not material to a
holder's decision whether to put the Securities to Celestica because the
consideration being paid to holders surrendering Securities consists solely of
cash, the Option is not subject to any financing conditions, the Option applies
to all outstanding Securities and Celestica is a public reporting company that
files reports electronically on EDGAR. The financial condition and results of
operations of Celestica and its subsidiaries are reported electronically on
EDGAR on a consolidated basis.
(b) Not applicable.
ITEM 11. ADDITIONAL INFORMATION.
(a) Not applicable.
(b) Not applicable.
ITEM 12. EXHIBITS.
(a)(1)(A) Company Notice to Holders of Celestica Inc. Liquid Yield
Option(TM)Notes due 2020 (Zero Coupon-Subordinated), dated July 5, 2005.
(a)(1)(B) Form of Purchase Notice, dated July 5, 2005.
(a)(1)(C) Form of Notice of Withdrawal, dated July 5, 2005.
1
(a)(1)(D) Form W-9.
(a)(5)(A) Press Release issued by Celestica Inc. on July 5, 2005.
(a)(5)(B) Summary Advertisement
(b) Not applicable.
(d) Indenture, dated as of August 1, 2000, between Celestica Inc. and
JPMorgan Chase Bank, N.A. (as successor to The Chase Manhattan Bank),
incorporated by reference to Exhibit 4.1 to Celestica's Registration Statement
on Form F-3 (File No. 333-12272), as filed with the Securities and Exchange
Commission on July 24, 2000.
(g) Not applicable.
(h) Not applicable.
ITEM 13. INFORMATION REQUIRED BY SCHEDULE 13E-3.
(a) Not applicable.
2
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
Dated: July 5, 2005 CELESTICA INC.
By: /s/ Elizabeth L. DelBianco
----------------------------
Elizabeth L. DelBianco
Chief Legal Officer
3
EXHIBIT INDEX
(a)(1)(A) Company Notice to Holders of Celestica Inc. Liquid Yield
Option(TM)Notes due 2020 (Zero Coupon-Subordinated), dated July 5, 2005.
(a)(1)(B) Form of Purchase Notice, dated July 5, 2005.
(a)(1)(C) Form of Notice of Withdrawal, dated July 5, 2005.
(a)(1)(D) Form W-9.
(a)(5)(A) Press Release issued by Celestica Inc. on July 5, 2005.
(a)(5)(B) Summary Advertisement
(b) Not applicable.
(d) Indenture, dated as of August 1, 2000, between Celestica Inc. and
JPMorgan Chase Bank, N.A. (as successor to The Chase Manhattan Bank),
incorporated by reference to Exhibit 4.1 to Celestica's Registration Statement
on Form F-3 (File No. 333-12272), as filed with the Securities and Exchange
Commission on July 24, 2000.
(g) Not applicable.
(h) Not applicable.